Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Compactin-a review.

R Chakravarti1, V Sahai

  • 1Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology-Delhi, Hauz Khas, 110016, New Delhi, India.

Applied Microbiology and Biotechnology
|March 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II study of elraglusib (9-ING-41), a GSK-3β inhibitor, in combination with gemcitabine plus nab-paclitaxel in previously untreated metastatic pancreatic cancer.

ESMO open·2025
Same author

14-3-3ζ suppresses RANKL signaling by destabilizing TRAF6.

The Journal of biological chemistry·2024
Same author

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.

ESMO open·2024
Same author

A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.

European journal of cancer (Oxford, England : 1990)·2024
Same author

Predictors of immunotherapy-induced immune-related adverse events.

Current oncology (Toronto, Ont.)·2018
Same author

Shelf-life enhancement of bio-inoculant formulation by optimizing the trace metals ions in the culture medium for production of DAPG using fluorescent pseudomonad R62.

Enzyme and microbial technology·2011
Same journal

Perfusion development and its potential for cell therapy manufacturing with adherent cells.

Applied microbiology and biotechnology·2026
Same journal

Bacterial degradation of aromatic ester pollutants in agro-ecosystems: implications for bioremediation.

Applied microbiology and biotechnology·2026
Same journal

Inhibiting biofilm growth on ammonium salt-functionalized or fluorinated voice prostheses silicone.

Applied microbiology and biotechnology·2026
Same journal

Enhancing reproducibility in mixing time determination of stirred tank reactors via automated analysis and standardized inter-laboratory trials.

Applied microbiology and biotechnology·2026
Same journal

Hybrid genome assembly and phenotypic assays reveal carbohydrate metabolism diversity in Lacticaseibacillus strains.

Applied microbiology and biotechnology·2026
Same journal

Ammonium and nitrate fluxes drive metabolic functional shifts in tap water biofilms.

Applied microbiology and biotechnology·2026
See all related articles

Compactin effectively inhibits HMG-CoA reductase, lowering cholesterol biosynthesis by reducing mevalonic acid. Fungal production of this hypocholesterolemic molecule has been significantly enhanced through various strategies and genetic advancements.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Molecular Biology

Background:

  • Compactin is a hypocholesterolemic agent.
  • It acts as a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase, a key enzyme in cholesterol biosynthesis.
  • Its structural similarity to HMG, the natural substrate, ensures specific and potent enzyme inhibition.

Purpose of the Study:

  • To review the chemistry, mode of action, pharmacology, biosynthesis, and production of compactin.
  • To provide a comparative analysis of different compactin production reports.
  • To highlight advancements in compactin yield optimization and genetic understanding.

Main Methods:

  • Literature review of existing studies on compactin.
  • Analysis of compactin's chemical properties and pharmacological effects.

Related Experiment Videos

  • Examination of fungal production methods and genetic sequencing data.

    • Main Results:

    • Compactin's inhibition of HMG-CoA reductase leads to reduced mevalonic acid levels and pleiotropic effects.
    • Commercial production using various fungi has achieved up to 900-fold yield increases.
    • The gene sequence responsible for compactin biosynthesis has been successfully cloned and sequenced.

    Conclusions:

    • Compactin is a significant molecule for cholesterol management due to its targeted inhibition of cholesterol biosynthesis.
    • Optimized fungal fermentation and genetic engineering offer substantial improvements in compactin production.
    • Further research into compactin's biosynthesis and pharmacology can unlock its full therapeutic potential.